IPP Bureau
ARScience Biotherapeutics appoints Gustavo Mahler as CEO
By IPP Bureau - June 17, 2026
Mahler brings more than 20 years of leadership experience spanning cell therapy, biopharmaceutical development, manufacturing, and global business management
Glenmark launches generic Methylene Blue Injection in US market
By IPP Bureau - June 17, 2026
Generic launch targets a US$19 million market in United States, strengthening Glenmark’s institutional and injectable product portfolio in North America
JLN Medical College launches robotic surgery programme in Rajasthan
By IPP Bureau - June 17, 2026
The launch event brought together policymakers, healthcare leaders, surgeons, and members of the medical fraternity to discuss the transformative role of robotic-assisted surgery
Can India become global clinical trials hub? Industry leaders to discuss road ahead on 19th June
By IPP Bureau - June 17, 2026
Leading experts from AIIMS Kalyani, Syngene, Veeda Lifesciences, Lambda Therapeutic, DNDi, JSS Medical, KIHT, InoRx, ISCR and SIRO Clintech to discuss India’s readiness as preferred clinical research destination
BD India and HOPE Foundation empower 264 youth through skill development initiative
By IPP Bureau - June 17, 2026
Partnership enters its ninth year after training over 2,200 young people and enabling employment for more than 1,750 beneficiaries through nursing assistant and digital skills programs
Jaslok Hospital performs advanced robotic surgery to remove early rectal cancer
By IPP Bureau - June 17, 2026
Robotic TAMIS procedure helps 75-year-old patient avoid rectum removal and permanent stoma, enabling faster recovery and preserving quality of life
Life sciences firms move from AI pilots to scaled adoption, finds KPMG Global Tech Report 2026
By IPP Bureau - June 17, 2026
Report reveals growing confidence in AI-driven decision-making, but highlights persistent challenges in scaling digital investments and converting innovation into measurable business value
Menthra launches AI-powered emotional wellbeing platform in India
By IPP Bureau - June 17, 2026
Founded by serial entrepreneur Dinakara Nagalla, the platform enters the Indian market with 30,000 users, and 500 wellbeing professionals
Indian pharma market logs sixth straight month of double-digit growth in May
By IPP Bureau - June 17, 2026
Market grows 12.1%; volume contribution improves as 9 out of 10 key therapies post double-digit growth
Vygon secures Health Canada approval for next-generation Stiletto Extended-Dwell Catheter
By IPP Bureau - June 17, 2026
Approval paves the way for expansion in North America’s growing vascular access market, with innovative SlipStream technology designed to simplify catheter insertion and enhance patient care
Alithea Genomics and Revvity expand global access to scalable transcriptomics platforms
By IPP Bureau - June 16, 2026
Collaboration integrates MERCURIUS DRUG-seq technologies with Revvity’s screening portfolio, enabling scalable transcriptomic profiling for next-generation drug discovery and AI-driven research
Lumos Health opens applications for second cohort of HealthTech and MedTech startups
By IPP Bureau - June 16, 2026
Healthcare speed-scaling platform offers clinical validation, regulatory support, mentorship, and investor access to startups working across preventive health, oncology, genomics, diagnostics, and digital health
India’s bioeconomy grew 20-fold in last 12 years: Dr Jitendra Singh
By IPP Bureau - June 16, 2026
From a $10 billion bioeconomy to over $190 billion, indigenous CAR-T therapy, and a booming startup ecosystem highlight 12 years of transformation in India’s science and technology landscape
FDA clears Dexcom’s Stelo as first OTC Continuous Glucose Monitor for kids
By IPP Bureau - June 16, 2026
Expanded indication makes Stelo the first FDA-cleared OTC CGM for children aged two years and older with diabetes or prediabetes
